Tel Aviv - Delayed Quote • ILA Pulsenmore Ltd. (PULS.TA) Follow Compare 416.80 +15.70 +(3.91%) As of 1:07:48 PM GMT+2. Market Open. All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations Pulsenmore Expands Partnership with Clalit Health Services to Deliver 25,000 Home Ultrasound Devices for Remote Prenatal Care Pulsenmore (TASE: PULS), a pioneering provider of home-based ultrasound technology, has announced the renewal and expansion of its strategic partnership with Clalit Health Services, Israel's largest HMO. Over the next five years, Pulsenmore will supply 25,000 units of its advanced home ultrasound devices to support Clalit's commitment to accessible, high-quality prenatal care. Pulsenmore Appoints Len Farris as Chief Commercial Officer to Lead Global Expansion of Breakthrough Home Ultrasound Technology Pulsenmore Ltd. (TASE:PULS), a pioneer in home ultrasound imaging technology, proudly announces the appointment of Len Farris as Chief Commercial Officer. Farris will lead Pulsenmore's global commercial growth, overseeing sales, business development, and partnerships. Pulsenmore is expanding the application of its home ultrasound solution for pregnant women: a clinical trial with Michigan Medicine will focus on the remote assessment of the fetal biophysical profile Pulsenmore (TASE:PULS), the world leader in self-scan ultrasound technology for at-home use and remote clinical diagnosis, announces its new clinical study collaboration with Michigan Medicine. The study will examine the ability to conduct a remote biophysical profile (BPP) test, by using the Pulsenmore home ultrasound with the guidance of a remote clinician, potentially reducing the clinical burden. Performance Overview Trailing total returns as of 1/19/2025, which may include dividends or other distributions. Benchmark is TA-125 Return PULS.TA TA-125 YTD -10.65% +8.28% 1-Year -35.70% +38.76% 3-Year -69.82% +22.41%